Press Releases - Kerecis

Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

Kerecis Communications July 7, 2023 No Comments

Today Coloplast announced the following statement. We’re excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration. We’re committed to making a…

Kerecis, the Medical-Fish-Skin Company, Recognized for its Extraordinary Growth

Kerecis Communications May 10, 2023 No Comments

Nordic Scaleup Award also recognizes the company’s long-term commitment to sustainability STOCKHOLM–(BUSINESS WIRE)–Nordic Scaleup Summit– Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in…

Kerecis Combines Fish-Skin Graft and Silicone Cover for Wound Treatment

Kerecis Communications April 27, 2023 No Comments

New product and results of clinical study announced at SAWC NATIONAL HARBOR, Md.–(BUSINESS WIRE)–SAWC – Kerecis® today announced MariGen® Shield, which integrates the company’s proven fish-skin graft with a silicone…

More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment

Kerecis Communications April 19, 2023 No Comments

Millions more Americans are now eligible for insurance coverage for Kerecis’ medical-fish-skin technology. Many U.S. private insurers recently rated Kerecis Omega3 MariGen as “medically necessary” for diabetic foot ulcers that…

Kerecis Named One of Europe’s Fastest Growing Companies by Financial Times

Kerecis Communications March 21, 2023 No Comments

Company ranked fifth in the FT1000 healthcare and life sciences category. Reykjavik, Iceland and Arlington, Virginia — March 21, 2023 Kerecis® has been included in the FT1000 list of Europe’s…

Kerecis Announces New Fish-Skin Burn Products

Kerecis Communications January 21, 2023 No Comments

ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, today announced the release of two new products…

Medical Fish Skin Company Kerecis to Participate in the Biotech Showcase 2023 and the J.P. Morgan Healthcare Conference

Kerecis Communications January 6, 2023 No Comments

ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, today announced that the company will be attending…

$100 Million Financing from LEGO Owner KIRKBI and Others values Medical-Fish-Skin Company Kerecis at $620 million

Kerecis Communications July 20, 2022 No Comments

The investment in environmentally sustainable technology will help thousands more patients with burned or damaged skin tissue Reykjavik, Iceland, Billund, Denmark and Arlington, Virginia — July 21, 2022 — Today it…

Atrium Health’s Sanger Heart & Vascular Institute First in the World to Use Implantable Fish-Skin Grafting in Reconstructive Surgery 

Kerecis Communications July 7, 2022 No Comments

CHARLOTTE, N.C., and Arlington, VA – July 6, 2022 – Atrium Health’s Sanger Heart & Vascular Institute has received a Center of Excellence designation from Kerecis®, the company pioneering the…

Medical-Fish-Skin Company Kerecis and Arctic Circle Partner to Focus Attention on the Future of the Arctic

Kerecis Communications April 1, 2022 No Comments

Reykjavik, March 30, 2022 — Kerecis and Arctic Circle announced today that they will partner to increase attention on the rapid changes in the Arctic. The partnership will allow Kerecis…

Kerecis to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference on Monday and Tuesday, February 14 and 15, 2022

Kerecis Communications February 15, 2022 No Comments

Medical fish skin company Kerecis is participating in meetings at the SVB Leerink Annual Global Healthcare Conference Mon. & Tues, Feb. 14 and 15. ARLINGTON, Va. & REYKJAVIK, Iceland– Kerecis,…

Kerecis Announces First-Ever Fish-Skin Implantable Medical Product for Surgery

Kerecis Communications October 19, 2021 No Comments

The new Kerecis® Omega3 SurgiBind™ is an FDA-approved implantable fish-skin graft for use in plastic and reconstructive surgery.

New Study Finds Statistically Significantly Faster Healing Rates for Diabetic Wound Patients Treated with Kerecis Fish Skin

Kerecis Communications September 21, 2021 No Comments

A study in Wounds reports statistically significantly higher healing rates for DFUs treated with Kerecis Omega3 fish skin compared to treatment with SOC.

Smiling Caucasian man in blue sport coat

Medical Fish Skin Company Kerecis Names Gudmundur Oskarsson VP Marketing & Product Management

Kerecis Communications August 18, 2021 No Comments

Having witnessed the type of damage and human suffering that Kerecis products can help prevent, he has a personal sense of the Kerecis mission. ISAFJORDUR and REYKJAVIK, ICELAND — August…

EY Announces Fertram Sigurjonsson of Kerecis as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Winner

Kerecis Communications August 4, 2021 No Comments

ARLINGTON, VIRGINIA – August 3, 2021 – Ernst & Young LLP (EY US) today announced that Kerecis Founder and CEO Fertram Sigurjonsson was named an Entrepreneur Of The Year® 2021…

Category: Press Releases

Products